{"entity":{"id":"nct01124253","kind":"trial","name":"Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)","aka":[],"tldr":"A phase 3 trial of Recombinant human endostatin in Non-small-cell lung cancer, run by Shanghai Jiao Tong University School of Medicine, completed.","summary":"Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) is a phase 3 interventional study registered as NCT01124253 by Shanghai Jiao Tong University School of Medicine, with 250 participants recorded, started 2007-07 and reaching its primary completion in 2009-10. Interventions recorded: recombinant human endostatin. Conditions recorded: Non-small Cell Lung Cancer.\n\nLinked to the drug Recombinant human endostatin because the registry names it among its interventions and Non-small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01124253","url":"https://clinicaltrials.gov/study/NCT01124253"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["recombinant-human-endostatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01124253","phase":"3","setting":"Phase III Study of Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer","sponsor":"Shanghai Jiao Tong University School of Medicine","enrolled":250,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01124253/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"recombinant-human-endostatin","kind":"drug","name":"Recombinant human endostatin","route":"/drugs/recombinant-human-endostatin/"}]}}